161 related articles for article (PubMed ID: 23056525)
1. Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation.
Honda K; Okusaka T; Felix K; Nakamori S; Sata N; Nagai H; Ioka T; Tsuchida A; Shimahara T; Shimahara M; Yasunami Y; Kuwabara H; Sakuma T; Otsuka Y; Ota N; Shitashige M; Kosuge T; Büchler MW; Yamada T
PLoS One; 2012; 7(10):e46908. PubMed ID: 23056525
[TBL] [Abstract][Full Text] [Related]
2. Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometry.
Chen J; Anderson M; Misek DE; Simeone DM; Lubman DM
J Chromatogr A; 2007 Aug; 1162(2):117-25. PubMed ID: 17434173
[TBL] [Abstract][Full Text] [Related]
3. Possible detection of pancreatic cancer by plasma protein profiling.
Honda K; Hayashida Y; Umaki T; Okusaka T; Kosuge T; Kikuchi S; Endo M; Tsuchida A; Aoki T; Itoi T; Moriyasu F; Hirohashi S; Yamada T
Cancer Res; 2005 Nov; 65(22):10613-22. PubMed ID: 16288055
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum diagnosis of pancreatic cancer by using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Gao H; Zheng Z; Yue Z; Liu F; Zhou L; Zhao X
Int J Mol Med; 2012 Nov; 30(5):1061-8. PubMed ID: 22941199
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
6. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
7. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.
Flood-Nichols SK; Tinnemore D; Wingerd MA; Abu-Alya AI; Napolitano PG; Stallings JD; Ippolito DL
Mol Cell Proteomics; 2013 Jan; 12(1):55-64. PubMed ID: 23059768
[TBL] [Abstract][Full Text] [Related]
9. Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.
Honda K; Kobayashi M; Okusaka T; Rinaudo JA; Huang Y; Marsh T; Sanada M; Sasajima Y; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Miura N; Kamita M; Sakamoto T; Shoji H; Jung G; Srivastava S; Yamada T
Sci Rep; 2015 Nov; 5():15921. PubMed ID: 26549697
[TBL] [Abstract][Full Text] [Related]
10. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry.
Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T
J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372
[TBL] [Abstract][Full Text] [Related]
11. Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
Tiss A; Timms JF; Smith C; Devetyarov D; Gentry-Maharaj A; Camuzeaux S; Burford B; Nouretdinov I; Ford J; Luo Z; Jacobs I; Menon U; Gammerman A; Cramer R
Int J Gynecol Cancer; 2010 Dec; 20(9):1518-24. PubMed ID: 21370595
[TBL] [Abstract][Full Text] [Related]
12. Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology.
Jin XL; Xu B; Wu YL
World J Gastroenterol; 2014 Oct; 20(40):14958-64. PubMed ID: 25356057
[TBL] [Abstract][Full Text] [Related]
13. Direct targeting of human plasma for matrix-assisted laser desorption/ionization and analysis of plasma proteins by time of flight-mass spectrometry.
Jin Y; Manabe T
Electrophoresis; 2005 Jul; 26(14):2823-34. PubMed ID: 15934056
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers screening between preoperative and postoperative patients in pancreatic cancer.
Li P; Yang J; Ma QY; Wu Z; Huang C; Li XQ; Wang Z
Asian Pac J Cancer Prev; 2013; 14(7):4161-5. PubMed ID: 23991970
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry.
Lin CH; Su H; Hung CC; Lane HY; Shiea J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361610
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic protein discovery using proteolytic peptide targeting and identification.
Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion.
Qian J; Liu T; Yang L; Daus A; Crowley R; Zhou Q
Anal Biochem; 2007 May; 364(1):8-18. PubMed ID: 17362871
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification.
Yu Y; Chen S; Wang LS; Chen WL; Guo WJ; Yan H; Zhang WH; Peng CH; Zhang SD; Li HW; Chen GQ
Oncology; 2005; 68(1):79-86. PubMed ID: 15864000
[TBL] [Abstract][Full Text] [Related]
20. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
